Skip to main content
Contact Us and FAQs
A-
A+
EN
繁
简
About the Academy
President's Welcome Message
History and Milestones
Governance
Our Objectives
Academy Colleges
Recognised Specialties and Fellows Register
Policy Statements, Corporate and Medical Publications
Academy Identity
Corporate Video
Academy Building
Academy Shop
Academy Fellows
Fellows' Handbook
Fellowship and Subscription
Specialist Registration
CME / CPD Principles and Guidelines
Accredited CME / CPD Activities
iCMECPD
Honours, Awards and Prizes
Fellow Benefits and Services
Nurturing Medical Leaders
Update Contact Details
Specialist Trainees
Information Pack
Academy e-Portfolio
Awards and Prizes
Extended Benefits and Services
Becoming an Academy Fellow
Career Advancement Support
Events and Services
Flagship and Annual Events
Events
Event Management Services
Venue Hire
Publication Services
Catering Services
Academy Lounge and Library
Professional Services
Our Initiatives
Advancement of Medical and Dental Education
Local and Global Collaborations
Institute for Medical Education and Development
eHKAM
SZ-HK Medical Specialist Training Centre
Academic Publications and Research
Medical Credentialling, Professionalism and Ethics
Promotion of Doctors’ Well-being
HKAM AI Portal
Media Corner
A-
A+
繁
简
Contact Us and FAQs
Follow Us
Primary tabs
•••
View
(active tab)
EDM Export
Auto Translate
Announcements from Department of Health
Breadcrumb
Home
Latest News
Announcements from Department of Health
Announcements from Department of Health
25 . 01 . 2024
Please note the following announcements from Department of Health:
Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate in the United Kingdom (Letter to Healthcare Professionals)
含mifepristone成分藥品安全資訊 (Letter to Healthcare Professionals) (Chinese only)
BCMA- and CD19-directed genetically modified autologous chimeric antigen receptor (CAR) T cell immunotherapies: risk of T cell malignancies (Letter to Healthcare Professionals)
Safety-related information for the product Mifegyne (Letter to Healthcare Professionals)